Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Coffee Lake Matters for Intel Corporation Stock

By Chris Lau, InvestorPlace Contributor

Intel is actively refreshing its CPU lineup to catch up to AMD. As the company continues to grow revenues, Intel stock still has more upside.

Why Alphabet Inc Still Has Massive Growth Ahead

By Chris Lau, InvestorPlace Contributor

Google stock is trading near its yearly highs, but it deserves to. Revenue growth will continue for Google, thanks to YouTube and mobile.

Why Micron Technology, Inc. Stock Has Deep Compelling Value

By Chris Lau, InvestorPlace Contributor

Bulls are expecting Micron to soar after another strong quarter. Investors should have time to buy Micron stock before the rally continues.

Wait for the Sony Corp Stock Pullback Before You Buy

By Chris Lau, InvestorPlace Contributor

SNE stock trades at a 17x forward P/E which is not high for a fast-growing entertainment firm. Still, wait before buying.

How Pfizer Inc. Stock Is Positioning for Solid Growth Ahead

By Chris Lau, InvestorPlace Contributor

Shares of PFE stock are fairly valued in the near-term. Plus there is potential for greater gains on the way.

Load More